MEGAN PEARCE: Open Payments
NPI 1154860138 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,691 in 81 payments from 8 companies in 2025. Trend: 2023 $4,457 · 2024 $690 · 2025 $4,691
Speaker / faculty: $2,000Food & beverage: $1,811Consulting: $880
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $2,807 |
| Celltrion USA Inc. | 10 | $1,128 |
| Janssen Biotech, Inc. | 19 | $345 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $226 |
| Janssen Scientific Affairs, LLC | 2 | $75 |
| Lilly USA, LLC | 4 | $67 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $24 |
| Ardelyx, Inc. | 1 | $18 |
Products named: ZYMFENTRA, TREMFYA, SKYRIZI, VEGZELMA, ENTYVIO, RINVOQ, OMVOH, XIFAXAN.
Industry payments across FL — which companies pay providers there.
